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Frozen shoulder is a common epidemiological affliction. Data acquired from people who
suffer from this type of damage in other joints such as the hip, wrist and ankle also
exist; although these syndromes are less common. Treatment for frozen shoulder is
primarily physical (physiotherapy, manual therapy), secondary medical (corticosteroid
injections) and finally surgical but with limited success. The difficulty in treating this type of
condition successfully lies in the lack of knowledge about the risk factors involved and the
pathophysiology underlying this mysterious syndrome. This review gives an overview of
the current scientific position of frozen shoulder in terms of evolutionary factors, etiology,
the different mechanisms of action involved, current treatment options and other possible
interventions based on recent discoveries of pathophysiological mechanisms. The overall
objective is to clarify several unknown aspects of a syndrome that affects up to 5% of
the world’s population.
Keywords: frozen shoulder, shoulder pain, low grade inflammation, microbiome, chronic hypoxia, fibrosis, insuline
resistance, sedentary life style
INTRODUCTION
Sometimes the shoulder joint becomes stiff, inextensible, and painful in a mysterious way, which
is how frozen shoulder (FS) presents itself. Its etiology can be both primary or secondary to other
conditions. Although frozen wrist (1), frozen hip (2) and frozen ankle (3) syndromes also exist,
FS is the most common “frozen” syndrome (4). It is a difficult condition to define and diagnose
precisely, as well as to treat effectively.
Some known risk factors for its development are diabetes, Dupuytren’s syndrome, thyroid
disease (especially hypothyroidism), nephrolithiasis, cancer, Parkinson’s disease, shoulder injury,
smoking, heart and neck surgery or chronic regional pain syndrome (5). Comorbidities occur in
85% of patients with FS and 37.5% have more than three comorbidities (6).
FS can be very disabling, and, against the current opinion of many health professionals, FS
does not resolve spontaneously in a large number of patients (7). Understanding the shared
pathways between FS and the aforementioned comorbidities opens the possibility to develop new
interventions based on common pathophysiological mechanisms such as insulin resistance and
low-grade inflammation (LGI).
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Epidemiology
The literature indicates that the incidence of FS is 2 to 5%
worldwide (8). The prevalence among the diabetic population
and those suffering from pathologies of the thyroid gland,
especially hypothyroidism may increase as high as 10 to 38% (9).
Most people who develop FS do so between 40 and 60 years of
age (10), being unusual in patients over 70 with the exception of
secondary traumatic FS (11). The incidence among women is 1.6
(12) to 4-fold higher than in men (4). Black/African Americans
and Hispanic/Latinos also show a higher prevalence (10). Type
1 diabetes is the greatest risk factor for the development of
FS, where the incidence can reach 59% in patients over 45
years of age with a lifetime prevalence of 76%. This group of
patients has greater associated disability, along with a greater
reduction in their range of mobility (13). The accumulated
level of glycated hemoglobin A1c (HbA1c) is a determining
factor, hence those patients with poorer blood glycemia
control accumulate an increased risk for the development
of FS (14).
Finally, incidence is also expressed with significant
contralateral differences p < 0.01: the non-dominant arm
is affected more than the dominant arm (58.9–41.1%) and the
left arm more than the right (53.4–46.6%) (15). Interestingly,
a hypothesis to explain FS is proposed by the authors of the
aforementioned study which states that the pathology could be
more related to an asymmetric control of the brain rather than
to some traumatic factor. The prognosis of FS is highly variable.
In contradiction to the common assumption that FS completely
resolves over time, a meta-analysis found this to be scientifically
invalid and that if left untreated, FS may persist for the more
than 3 years or even never resolve (7).
Pathogenesis of Frozen Shoulder
Mechanisms that may be key to the development of FS, such
as the accumulation of advanced glycation end products (AGE)
in the shoulder (16) associated with insulin resistance with
compensatory hyperinsulinemia (17), chronic hypoxia (18),
chronic LGI (19), and endotoxemia, also exist.
FS is characterized by the spontaneous onset of symptoms
such as pain, stiffness and progressive loss of mobility (20).
It presents in some cases, but not all, as a fibrotic state
with capsular and ligament involvement and an inflammatory-
based contracture that restricts the rotational interval of the
affected shoulder.
Although agreement on the development of FS is not unified,
it seems that it is proliferative, fibroblastic and inflammatory in
nature (21). Data from recent studies, using synovial biopsies
of patients with FS, have shown a chronic presence of immune
cells (mast cells, macrophages, T and B lymphocytes), as well as
inflammatorymediators including cytokines, such as interleukins
(IL)-1β, IL-6, IL-8, and tumor necrosis factor-alpha (TNF-
α) (22), and matrix metalloproteinases (MMPs) (23) in the
affected shoulder. These pathological mechanisms appear to be
responsible for the activation of fibroblast and deregulation in
collagen synthesis in people suffering from FS.
Another study showed the presence of S100 in 77% of the
research patient group suffering from FS (n = 22, 17 of 22).
S100 is a biomarker for the presence of neuronal tissue and
the increased presence of this nerve tissue could give a partial
explanation for the pain associated with FS (24).
The evaluation of cadavers and the use of open arthroscopic
surgery have shown synovial hyperplasia with increased
vascularization during the initial period (25). It ends with an
incipient fibrosis located mainly in the rotator cuff interval
(formed by the tendons of the subscapular, biceps and
supraspinatus muscles, and coracohumeral and superior
glenohumeral ligaments), together with the base of the coracoid
process (26) and in the subscapular recess (27).
The thickening of the coracohumeral ligament, which is the
roof of the rotator cuff interval, is indicated as one of the specific
manifestations of FS and the main limiting factor for external
rotation, although given its relationship with the subscapular and
supraspinatus tendons it also contributes to restricting internal
rotation (28). In more advanced stages of FS, the thickening and
contraction of the glenohumeral capsule culminates in limiting
the range of movement in all directions (25).
Recently, two studies in a subgroup of patients diagnosed with
FS have shown that there is no significant capsule restriction
(29, 30). In a sample of five patients with an indication for
capsulotomy (loss of active and passive mobility >40% in at least
two planes of movement in the affected shoulder relative to the
healthy one), it was found that under general anesthesia, the
movement of the affected shoulder was less restricted. All patients
showed a significant increase in their passive range of motion
(ROM), especially in abduction while under general anesthesia
conditions, compared to their ROM while awake. The subject
with the smallest improvement achieved an increase of 44◦ in
abduction under anesthesia (94◦ awake and 138◦ under general
anesthesia), while the subject with the greatest improvement
increased abduction by 83◦ under general anesthesia (55◦ awake
and 138◦ under general anesthesia) (29).
In a more recent study (30), the above research group
confirmed the results of their study carried out in 2015 with five
more patients suffering from FS and presenting with significant
loss of shoulder range of motion in abduction and external
rotation. Hollman L et al. again found that under general
anesthesia the range of motion improved in both abduction,
55◦ (from 55◦ awake to 110◦ under general anesthesia) in all
patients, and in external rotation, 25◦ (from 15◦ awake to 40◦
under general anesthesia) in three patients (30). This finding
supports the hypotheses of the existence of a fear-based brain
induced movement limitation, although more research is needed
to determine the number of patients suffering from this type
of FS.
The cited data help to better understand the development
of FS and show that progression has been made in regard to
the knowledge of the possible risk factors and the underlying
pathophysiological mechanisms causing FS. Although this
advance is clear, FS is still not completely understood and
epidemiological data show the need for further investigation
(4). The purpose of the review is to increase knowledge about
less known risk factors and pathophysiological mechanisms
which lead to the development of FS and also to propose new
interventions based on those factors and mechanisms.
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Frozen Shoulder and Its Possible
Evolutionary Origin
Bipedalism liberated the hands which made it easier for humans
to throw projectiles. The human shoulder evolved by optimizing
the storage and generation of elastic energy, especially in
the maximum range of external rotational movement, which
facilitated the launching of projectiles at high speed (31). From an
evolutionary perspective, manual work and the use of the upper
limbs, especially among women, used to be much higher than
today (32). Today’s lifestyle has dramatically decreased the use
of the upper limbs, in contrast to its evolutionary design, most
likely leading to atrophy of parts of the complex ligament capsule
of the shoulder (19).
The non-use of a body part can result in neuroanatomical
reorganization in different parts of the brain, such as occurs
with phantom pain (33) or in the production of pain or neglect
syndrome of that same part (34). The fear of pain or the fact that
little used tissue can be more easily damaged can produce a fear-
based brain reaction and generate a muscle defense response that
could lead to FS (30, 34).
The shoulder, the joint in the body with the greatest range
of motion, would have its movement further limited by this
possible muscle protection response (35). Lack of movement
may be responsible for chronic hypoxia in a joint that already
has low partial oxygen pressure (pO2) (36), providing a suitable
environment for the establishment of an inflammatory process
mediated by the activation of transcription factors such as
hypoxia- inducible factor 1 (HIF-1), nuclear factor Kappa B
(NF-kB) as well as the activation of several vascular and
endothelial growth factors (VEGF) and MMP 1, 3 and 13
(36) which are associated with inflammation, angiogenesis and
tissue destruction (37).
A sedentary lifestyle is a risk factor which does not depend
on the physical activity performed; it is also associated with
an increase in inflammatory activity and the development of
insulin resistance (38).
Similarly, oxidative stress associated with the presence of
inflammatory cytokines affecting different parts of the shoulder
ligament capsule complex may lead to an increased accumulation
of free radicals, advanced glycation end products and, probably,
subclinical alterations in both the connective tissue and the
extracellular matrix (19). The fact that the most affected shoulder
is the non-dominant one, commonly the left one (15) may
be indirect evidence that part of the pathophysiology of FS
is associated with a lack of movement and weakening of the
different joint tissues (ligaments, capsule, synovial sheath and
rotator cuff) as a result of “cerebral” joint immobilization and
associated muscle defense. Further proof that FS could be caused
by a lack of mobility associated with a neglect and/or muscular
defense is the fact that people who have suffered from hemiplegia
have a higher risk of suffering FS (39). A neglect syndrome
may also be significant evidence of having had hemiplegia
and could be the explanation for the risk of presenting FS
after a stroke (40). In short, it seems that the underuse of
the full range of motion in modern sedentary humans could
cause a predisposition for the development of FS. Other more
recent risk factors would then exacerbate the actual syndrome
called FS.
Chronic LGI, the Role of Alarmins,
Mechanical Stress, the Matrix
Metalloproteinases/Tissue Inhibitor of
Metalloproteases Ratio and Infection as
Postulated Mechanisms
Molecular biological studies suggest that angiogenesis,
infiltration of inflammatory cells, and increased expressions
of inflammatory cytokines such us cyclooxygenase (COX)-
1, COX-2, IL-1, IL-6, and TNF- α, are present in FS. The
inflammation might be the first manifestation of FS at the
molecular level, and COX-1, COX-2, IL-1, IL-6, TNF-α,
might play an important role in triggering, regulating, and
the remission of inflammation in FS (41). A chronic state of
low-grade infection/inflammation might predispose a person
to develop FS (42). Inflammatory lipoproteins such as low-
density lipoproteins (LDL) and non-high density lipoproteins
(non-HDL), associated with vascular inflammation and immune
reactions have been identified as independent risk factors for
FS (23, 43). Vascular endothelial cell activation is accompanied
by an increased expression of intercellular adhesion molecule-1
(ICAM-1), which has been shown to present elevated levels in
the joint capsule and synovial fluid of FS patients compared
to controls. Furthermore, the maintenance of chronic LGI has
been shown to produce phenotypic alterations in fibroblasts and
therefore lead to FS (21). This persistent fibroblast activationmay
play a role in the pathology of frozen shoulder and could explain
the cellular mechanisms behind capsular fibrosis and persistent
inflammation (21). Additionally, chronic inflammatory cells
including mast cells, T and B cells and macrophages have been
identified in shoulder capsule biopsies from patients with FS (44)
while diseased capsule showed dysregulated cytokines such as
IL-1β, IL-6 and TNF-α, which are known to drive inflammatory
and matrix interactions including fibroblast activation and
dysregulated collagen synthesis (45). In this context, the role
of alarmins, endogenous molecules that are released into the
extracellular milieu after infection or tissue injury and that signal
cell and tissue damage, may play a key role, and could explain the
cellular mechanisms behind capsular fibrosis and nerve growth.
Alarmins high mobility group box 1 (HMGB1), IL-33, S100A8,
and S100A9 have been shown to be elevated in the shoulder
capsule of patients with frozen shoulder when compared to
controls, as well as to be associated with significantly increased
neoinnervation linked to patient-reported pain (46).
HMGB1 has been shown to be induced by damage-associated
molecular patterns (DAMPs), cytokines, and certain states of
cellular stress, is considered crucial to the onset and perpetuation
of FS. The release of HMGB1 upon stress perpetuates the
inflammatory tissue response seen in patients. The significant
pain associated with frozen shoulder is linked to an increased
peripheral nerve ingrowth (47).
The involvement of IL-33 has been shown to be part of the key
pathologic features of angiogenesis and capsular tissue fibrosis
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since elevated nuclear expression of IL-33 in FS stromal cells has
been found. Moreover, IL-33, when released from the resident
tenocyte, has the ability to modulate inflammatory/matrix
crosstalk and thus, it is likely to be important in the balance
between reparation and degeneration in tissue repair.
It appears that in FS the S100 proteins are upregulated
in macrophages and are therefore likely to be involved in
macrophage differentiation and recruitment, which supports the
concept that FS has a strong inflammatory and immunological
origin (46). Under such circumstances, the extracellular matrix
(ECM) that the fibroblasts produce is altered and an imbalance
in ECM turnover appears, as well as an altered ratio between
MMPs and tissue inhibitor of metalloproteases (TIMPs), which
has been shown to be almost ten times lower in FS patients
vs. healthy controls (48). The synthesis and activity of MMPs
are controlled by TIMPs, cytokines, and growth factors (49).
In addition, studies have concluded that mechanical stress may
transduce cell signaling of mitogen-activated protein (MAP)
kinase by β1-integrin to change cytokines and MMPs in the
fibroblasts of FS (25).
Recently, another possible cause for the development of FS
has been described: an infectious one, related to several bacteria
that usually inhabit human skin. The most often identified is
Propionibacterium acnes (P. acnes), an anaerobic but aerotolerant
Gram-positive symbiont when it inhabits the skin (50). Although
several studies have found P. acnes in people with FS (50, 51) a
recent study is in favor of discarding this theory (52). However,
the infectious cause likely remains valid, based on data from
a study of 10 people with FS when they were compared to 10
patients with shoulder instability. The authors found multiple
alarmins (HMGB1, IL-33, S100A8, and S100A9) in the joint
capsule of the FS patient group in amounts consistent with an
infection, while in the control group they found no significant
increase of infection related markers (46).
P. acnes is an infectious bacterium probably underestimated
because, being anaerobic, it requires some adapted transport
system and a long incubation period (53). Its late growth in
favorable environments is often misinterpreted as contamination
(54). The systemic infectious potential of P. acnes together
with Streptococcus epidermis (S. epidermis) and Corynebacterium
propinquum (C. propinquum) is further supported by several
findings of P. acnes being responsible for disc herniation (55).
P. acnes is associated with the highest number of low-grade
infections after surgical procedures (56). Its access to the interior
of the body occurs through the mouth and teeth, mainly during
dental procedures and more importantly, on a daily basis during
tooth brushing (57). Recent studies show how an oral dysbiosis
contains microbial communities that can mediate inflammatory
pathologies both locally and remotely (58).
Another bacterial infiltration route in non-operated people
has been identified, namely the migration of bacteria in
a dormant stage into various cells including epithelials,
erythrocytes and adipocytes (59). The infiltration of these
bacteria into certain tissues depends on the level of oxygen
present. P. acnes is only able to proliferate in tissues with low pO2,
such as the intervertebral disc and perhaps a shoulder that lacks
movement. Currently, a clinical trial with 40 patients diagnosed
with FS is underway comparing the effect of using an antibiotic
with the application of prednisone (Clinical Trials.gov Identifier:
NCT03479502). In our opinion, based on the data, the risk of
endotoxemia as a mechanism of action linked to FS should not
be dismissed.
Current Therapies
Even though there is not a well-defined model for the
medical management of FS, there is a wide spectrum of
local treatments available, both surgical and non-surgical
(60). Frequently, the therapeutic management of FS varies
considerably among specialists based on personal experience
instead of published evidence (61).
It should be noted that none of the current therapeutic
options are universally accepted as the most effective in restoring
symptoms in patients with FS (62).
Common nonsurgical treatments include medication,
physical therapy, exercise, manipulation under anesthesia,
steroid injection or nerve blockers which can provide temporary
relief of symptoms (63). Most drug treatments target COX-1,
COX-2 and glucocorticoid receptors with a marginal effect on
inflammation and no impact on the accumulation of fibrotic
collagenous tissue (64). Surgical methods include open or
arthroscopic capsular release and hydrodilation, which improve
the shoulder range of motion and alleviate pain but leave
other complications (63).
Persistent pain and limited motion despite 3 to 6 months of
conservative treatment should be taken into account in the choice
of surgical treatment (65).
The treatment of frozen shoulder evolves according to the
stage of the syndrome (66, 67). Thus, during the freezing phase
(duration 10–36 weeks) pain is the most prominent symptom,
and steroid injections are the first choice of treatment (67). In
the frozen phase (4–12 months) restriction of joint movement
prevails; in this case, mobilization techniques and joint distension
are usually selected despite the limited evidence found (66).
Finally, in the thawing phase (12–42 months) there is a reduction
of pain and a progressive improvement of joint mobility. A recent
systematic review and meta-analysis shows how intra-articular
corticosteroid infiltrations are the prevalent intervention in the
non-surgical management of FS, especially for pain control and
joint function. The combination of corticosteroid infiltrations
and physiotherapy may offer some improvement in the pain
and freezing phase, with physiotherapy and manual mobilization
offering the most benefit in the adhesive phase of the injury (68).
In Figure 1 we propose an outline of the pathophysiology of
FS, both at the diagnostic and therapeutic levels. In blue, we
show the process associated with the “idiopathic” development
of FS. In green, the process related with the development
of traumatic FS, for instance by repeated throwing in sports
such as baseball or handball. In yellow, we indicate the
interventions aimed at the risk factors and mechanisms of
action responsible for this mysterious pathology. In white,
we highlight the pathologies associated with a greater risk of
developing FS. The mechanisms of action discussed in this
review provide a reasonable explanation for these associations.
We must make clear that Dupuytren’s syndrome is not the
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FIGURE 1 | Current and proposed pathways leading to the Frozen Shoulder Syndrome; from the photo to the film.
cause of frozen shoulder, but a comorbid pathology connected
to the same pathophysiology behind both FS and Dupuytren,
including insulin resistance, LGI and low-grade infection (46).
The interventions mentioned in Figure 1 aim to offer a solution
with the least number of side effects.
Frozen shoulder can be primary (idiopathic) or secondary
(traumatic). Baseball and handball players often suffer complete
ruptures of the rotator cuffmuscles leading to surgical operations
and long-term immobilization. The inability to resolve the
inflammatory process promotes the establishment of a chronic
LGI process in an environment of chronic hypoxia. The
consequence of this state is an increased production of free
radicals and the formation of fibrosis. The idiopathic route is
associated with a neglect syndrome and a sedentary lifestyle.
Sedentary living is the main risk factor for the development of
insulin resistance and the accumulation of advanced glycation
end products in the ligamentary and capsule areas of the non-
dominant shoulder. The lack of voluntary movement generates
chronic hypoxia and an environment which is suitable for the
infiltration of a dormancy microbiome, especially anaerobic
bacteria such as P. acnes. The low-grade infection induces the
infiltration of immune cells, inflammatory cytokines, free radicals
and finally the frozen shoulder.
Proposed Interventions Based on
Postulated Mechanisms
Based on the systemic nature of the postulated pathogenic
mechanisms and given the limitation of publications with this
approach, we propose a series of interventions aimed at the
mechanisms of action described and perfectly complementary
to current treatments which, in our opinion, deserve to be
investigated in the field of FS.
Endotoxemia and Infection
Today’s lifestyle is conducive to many health risks factors (69).
Hormonal factors such as those associated with long-term stress,
or dietary factors, either through increased consumption of
foods with a high density of food additives or through the
high consumption of gliadin-rich cereals pose threats to the
integrity of cell-binding complexes (70). Increased permeability
of body barriers is associated with a high risk of endotoxemia,
chronic inflammation and insulin resistance (71). In a recent
systematic review, most of the included studies showed a higher
concentration of lipopolysaccharides (LPS) in diabetic patients
than in healthy subjects (72).
Endotoxemia and P. acnes infection have been proposed as a
possible mechanism linked to FS. Even though it has not been
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tested with patients suffering from FS, there are several in vitro
and in vivo studies demonstrating lactoferrin’s ability to protect
against microbial infections. Lactoferrin plays an important
role in several physiological processes including antimicrobial,
antioxidant, anticarcinogenic, and anti-inflammatory properties
(73). It exhibits inhibitory effects against several Gram-
positive and Gram-negative species, including some strains
that are antibiotic resistant (74). The nature of lactoferrin’s
mechanism of action is both, bacteriostatic and bactericidal.
In a recent paper, the presence of an anti-inflammatory
effect of lactoferrin on P. acnes-induced inflammation, both
in vitro and in vivo was noticed (75). The beneficial effects
of oral administration of lactoferrin have been proven in
two randomized, double-blind, placebo-controlled trials (n =
164, n = 36) (76) as well as in a systematic review and
meta-analysis (77).
Another intervention to be tested in order to improve
endotoxemia is glutamine supplementation which may improve
tissue integrity, especially in the gut, by facilitating enterocyte
proliferation and the expression of tight junctions (78). In
a randomized controlled study, Benjamin et al. showed how
glutamine supplementation in patients with Crohn’s disease in
remission reduced the permeability of the gut (79). Although
the results in animal models are very encouraging, human
studies are still predominantly observational, unclear, and need
to be standardized.
The use of prebiotics can modify the microbiota
by selectively stimulating the growth and/or activity of
beneficial bacteria in the gut (80). Some of the most
common prebiotics are fructo-oligosaccharides (FOS) (81),
which can be obtained naturally from daily consumption
of vegetables, fruits and some cereals. The fiber present in
these foods is specifically fermented by certain bacteria, such
as bifidobacterial, among others (82). Prebiotics not only
provide a source of energy for our bacteria, but also have
some health benefits, such as providing both acute and chronic
inflammatory relief (83).
Probiotics regulate the immune response by activating
specific genes in host cells (82). Specific strains such as
Lactobacillus reuteri (L. reuteri) or Enterococcus faecium (E.
faecium) can increase the production of IL-10 (84). IL-10 inhibits
both cytokine and inflammatory chemokine production (85).
In vitro studies have shown that lipoteichoic acid isolated
from Lactobacillus plantarum (L. plantarum) improves the
inflammatory response by inhibiting the production of TNF- α
and IL-6 (86). In a recent double-blind randomized placebo-
controlled study, Toshimitsu T et al. demonstrated in 130
participants how the ingestion of a yogurt rich in L. plantarum
for 12 weeks significantly improved glucose metabolism in pre-
diabetic adults. They found that HbA1c values were significantly
lower than in the control group. The authors stress the
importance of improving this parameter since the study did not
consider any other lifestyle-based intervention such as caloric
restriction or increased physical activity. They suggest that
using these types of probiotics optimizes HbA1c through the
improvement produced in the chronic inflammatory process and
insulin resistance (87).
Chronic Low-Grade Inflammation
We speculate that multiple signaling pathways, postulated as
mechanisms belonging to FS, could be positively influenced by
different compounds found in plants.
One of the alarmins considered crucial for the perpetuation of
frozen shoulder is HMGB1 (46) which is released by activated
macrophages/monocytes functioning as a late inflammatory
mediator (88). It binds to Receptor for Advanced Glycation
End Products (RAGE) which activates Mitogen-activated protein
Kinases and NF-kB. Recently, several herbal medicines have
been tested as HMGB1 inhibitors (89). Epigallocatechin, and
epicatechin, polyphenolic compounds found in green tea
(Camellia sinensis), have been measured in vivo to completely
inhibit HMGB1 at a dose as low as 10µl/ml (equivalent
to 75 ml/person, assuming a total body weight of 75Kg,
and blood volume of 7,500ml) and with no measured
toxicity in macrophage cultures (90). Other plants rich in
polyphenolic compounds, frequently used in Chinese medicine,
and with HMGB1 inhibitor properties are Panax ginseng (91),
Angelica sinensis and Salvia miltiorrhiza (92). Further interesting
polyphenolic compounds are those found in Ecklonia cava, a
brown algae recognized as a food ingredient, and also found
in the form of a supplement in Japan and Korea. Phlorotannin
rich extracts found in E. cava attenuated serum levels of nitric
oxide (NO), prostaglandins E2 (PGE2) and HMGB1in murine
models (89).
The alteration of the MMPs/TIMPs ratio, which has been
shown to be ten times lower in FS patients vs. healthy controls
(48), might be influenced by natural substances. Three major
groups of natural substances derived from plants have grown in
interest because they have been shown to interfere with MMPs
expression: flavonoids, green tea polyphenols and curcumin. Due
to their use as food components, the risk for major toxicity and
side effects seems to be very small, and epidemiologic data suggest
a satisfying level of bioavailability (93).
In vitro studies have demonstrated that flavonoids such
as genistein and nobiletin downregulate MMP-2 synthesis
by inhibiting tyrosine kinases (94). Epigallo-catechin gallate
(EGCG) from green tea reduces the activation of MMP-2,
downregulates the MMP-2/9 expression and induces apoptosis
(95). Finally, the following effects of curcumin have been shown:
antiproliferative effect, induction of apoptosis by downregulation
of antiapoptotic proteins, such as Bcl-2, suppression of
NF-kB, inhibition of activating protein-1 (AP-1) signaling
pathway, inhibition of MAPK pathway and the serine protein
kinase pathway (96).
Dominiak K.et al. examined whether consumption of a
formulation based on curcumin, resveratrol, EGCG and soy
isoflavones could protect human lymphocytes against oxidative
stress induced by ex vivo exposure of lymphocytes to TNF-α.
This pilot study supports the use of certain natural agents in
supplemental form as they may protect humans against oxidative
damage and inflammation (97).
Chronic Pain and Loss of Mobility
IL-33 plays a pivotal role in FS in relation to pain, inflammation,
angiogenesis and capsular tissue fibrosis (46). Naringenin, found
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in citrus, is a flavonoid with low toxicity and anti-inflammatory
properties (98). In mice, Pinho-Ribeiro et al. tested the analgesic
effect of this flavonoid in mechanical inflammatory pain with
control groups using anti-inflammatory drugs indomethacin
or dipyrone. The results suggest that naringenin inhibits both
inflammatory and neurogenic inflammation. Its mechanism of
action involves the inhibition of hyperalgesic cytokines (IL-33,
TNF- α and IL-1β) (99).
The type of pain in FS is nociceptive as a result of all the
peripheral abnormalities associated with the capsular structures.
However, chronic inflammatory mediators play a role in the
process of central sensitization (100). Cytokines and other local
inflammatory components released by the inflamed environment
may be responsible for both central and peripheral sensitization
(101). Until now, central sensitization in FS has not been studied
and so remains speculative, but this could explain why some
patients are resistant to current interventions and may benefit
from a different approach (100).
In this context, mirror therapy has proved to be effective in
patients who suffered from phantom limb, complex regional pain
syndrome or stroke, where central sensitization is present (102).
Along the same line, two limited studies have been published
regarding patients suffering from adhesive capsulitis or chronic
shoulder pain with limited active range motion (AROM). Louw
A. et al. measured the effects of mirror therapy in 69 patients
with shoulder pain and limited AROM and found a significant
increase (mean 14,5◦) in affected shoulder flexion AROM,
immediately after mirror therapy (P < 0.001). They also noticed
a statistically significant improvement in pain and fear avoidance
facilitating the transition to manual therapy and exercise in
these patients (103). Başkaya C.T. et al. enrolled 30 patients
diagnosed with adhesive capsulitis in a prospective, randomized,
controlled, single-blind clinical study and found a significant
increase of active and passive abduction and active and passive
flexion ROM compared with the control group that received
standard physical therapy. A significant improvement was noted
in physical function, physical role limitation, emotional role
limitation and pain parameters in the mirror group, whereas
there were no significant changes in the control group (104).
Mirror therapy is an easy, non-invasive and cheap therapy
consisting of the use of a mirror that reflects the movement of
the unaffected part of the body, while the affected limb remains
hidden (not visible). The rationale for using mirror therapy is
based on the brain recovering the presence of the affected arm
as being normal and as an anti-neglect intervention through
visual stimulation.
A meta-analysis has measured the efficacy of using
supplements rich in omega-3 fatty acids and their analgesic
effect on inflammatory joint pain, highlighting how
eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA) supplementation reduces the intensity of joint pain,
morning stiffness and non-steroidal anti-inflammatory drugs
(NSAID) consumption (105).
In patients with regional pain syndrome, Jung et al. found
that diet is associated with neuroinflammatory processes and
that neuroinflammation is associated with peripheral glucose
levels, among other things (106). In our opinion, the potential
of a ketogenic diet is worth exploring because of its ability
to influence glucose metabolism, inflammation and pain. This
high-fat, low-carbohydrate diet stimulates liver ketogenesis and
the production of acetone, acetoacetate, and β-hydroxybutyrate
(bHB) as alternative energy sources (107). The ketone bodies
have functions that go beyond acting as energy resources,
especially bHB, which can act on multiple levels. bHB shortens
oxidative stress by inhibiting the activity of histone deacetylases
class I (HDAC-I) and could further reduce the inflammatory
and sympathetic system activity and increase neuroprotection
through regulation of coupled G-protein receptors (GPR) and
immune cells via GPR109 (108).
bHB also inhibits the NLR family, pyrin domain-containing
3 (NLRP3) inflammasome, which results in an inhibition in
the production of inflammatory cytokines such as IL-1 and
IL-18 (109). This pathway may be highly significant, since
P. acnes is responsible for activating NLRP3 (110) within
the pathophysiology of intervertebral disc degeneration. Both
animal and human model studies have shown how a 3 to
4 weeks ketogenic diet results in both inflammatory and
pain improvements (111).
CONCLUSIONS
This study presents a systemic view on the pathogenesis of
frozen shoulder with the strength of evidence-based medicine
as the basis of a systemic proposal for both the diagnostic and
therapeutic levels. FS is a dysfunction related to pathologies such
as diabetes, Parkinson’s, Dupuytren’s and hypothyroidism. The
mechanisms of action related to the aforementioned pathologies
include low-grade inflammation and chronic hypoxia. These
mechanisms, together with the influence of modern life,
including a sedentary lifestyle, and the partial or complete
absence of range of motion of the shoulders in general and
of the non-dominant shoulder in particular, suggest that the
pathology of FS is systemic. A systemic pathology requires a
systemic intervention. Our proposal offers a systemic view for
people afflicted with FS. Although robust evidence is still lacking,
the treatment described in this review deserves to be investigated
using different clinical trials. The proposed interventions do not
place a large burden on the patient. FS does not seem to resolve
itself, although this paradigm still persists, and more research is
needed to corroborate it. The systemic approach proposed in this
review could serve as the missing link to improve the success rate
in people suffering from FS.
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